• 23. Dezember 2024

Results of Cervical Cancer Study Sponsored by ISA Pharmaceuticals to Be Presented at ASCO-SITC

ByISA Pharmaceuticals

Feb 16, 2017
– First data of phase I/II trial in HPV16-positive patients with late-stage cervical cancer
Teile den Beitrag mit Freunden